Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Gains from Investment Securities (2017 - 2025)

Cue Biopharma (CUE) has disclosed Gains from Investment Securities for 9 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 93.16% to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2025, up 93.16% year-over-year, with the annual reading at $2.7 million for FY2025, 93.16% up from the prior year.
  • Gains from Investment Securities hit $2.7 million in Q4 2025 for Cue Biopharma, down from $13.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $13.8 million in Q3 2025 to a low of $35000.0 in Q3 2021.
  • Historically, Gains from Investment Securities has averaged $3.4 million across 5 years, with a median of $1.6 million in 2022.
  • Biggest YoY gain for Gains from Investment Securities was 10108.33% in 2021; the steepest drop was 85.11% in 2021.
  • Year by year, Gains from Investment Securities stood at $35000.0 in 2021, then skyrocketed by 4688.57% to $1.7 million in 2022, then surged by 53.75% to $2.6 million in 2023, then plummeted by 45.5% to $1.4 million in 2024, then skyrocketed by 93.16% to $2.7 million in 2025.
  • Business Quant data shows Gains from Investment Securities for CUE at $2.7 million in Q4 2025, $13.8 million in Q3 2025, and $1.5 million in Q2 2025.